Pharmaceutical Supply Chain Strategy in a Tariff-Driven Era

The pharmaceutical supply chain strategy has fundamentally shifted as trade tariffs, pricing mandates, and global policy disruptions expose deep vulnerabilities across the value chain. Rising API costs, drug shortages, and regulatory unpredictability are forcing companies to rethink sourcing, manufacturing, and risk frameworks. For more info: https://www.zs.com/insights/us....-pharma-policy-strat